Is the price fair?
What STAA's price assumes
STAAR Surgical Company did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 3.54× revenue.
3.54
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.92
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 2.92
- EV / EBIToperating margin −9.1%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $1.45B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #1 of 27 by Smart Score